Microba Life Sciences Limited (ASX: MAP)
Australia
· Delayed Price · Currency is AUD 0.195
+0.010 (5.41%)
Dec 27, 2024, 3:28 PM AEST
Microba Life Sciences Market Cap
Microba Life Sciences has a market cap or net worth of 87.33 million as of December 27, 2024. Its market cap has decreased by -4.34% in one year.
Market Cap
87.33M
Enterprise Value
67.82M
Revenue
12.09M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.20
Market Cap Chart
Since April 5, 2022, Microba Life Sciences's market cap has decreased from 96.03M to 87.33M, a decrease of -9.05%. That is a compound annual growth rate of -3.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 27, 2024 | 87.33M | 8.33% |
| Dec 29, 2023 | 80.61M | -29.31% |
| Dec 30, 2022 | 114.03M | 18.75% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 135.94B |
| ResMed Inc. | 55.15B |
| Pro Medicus Limited | 26.14B |
| Fisher & Paykel Healthcare Corporation Limited | 20.33B |
| Cochlear Limited | 19.42B |
| Sonic Healthcare Limited | 13.23B |
| Telix Pharmaceuticals Limited | 8.37B |
| Ramsay Health Care Limited | 7.94B |